CAR-T cells – new indications and managing haematotoxicity
Tracks
Track 3
| Monday, April 29, 2024 |
| 3:00 PM - 4:30 PM |
| Room 3A |
Speaker
Dr. Andrea Kuhnl
Consultant Haematologist
King's College Hospital
5 years of CAR T-cell therapy for LBCL in the UK - lessons learnt
3:00 PM - 3:20 PM
Prof. Marion Subklewe
Head Of Immunotherapy In Hematology, Professor
LMU University Hospital Munich
IEC-associated haematotoxicity
3:20 PM - 3:40 PM
Dr. Kanagaraju Ponnusamy
Research Associate
Imperial College London
Optimisation, Off-the-Shelf, CAR-iNKT Immunotherapy to treat Multiple Myeloma
3:40 PM - 3:55 PM
Dr Georgina Anderson
MRC Postdoctoral Fellow
MRC Toxicology Unit
And-Gate CAR T-Cells to Improve Tumour Specificity and Targeting of Low-Expression Antigens in Multiple Myeloma
3:55 PM - 4:10 PMChair
Reuben Benjamin
